News Detail
New Delhi, 17 Feb 2025: Enhertu, an oncology drug marketed by UK giant AstraZeneca, topped the list of highest-selling new drugs in 2024, generating sales of nearly Rs 58 crore within its first year of launch. A cancer drug topping the sales charts also highlights the growin......
View Details
Source : Economic Times
Enhertu sales
top selling cancer medications
cancer drug market
AstraZeneca new drug launch
pharmaceutical market growth
oncology drug sales 2024
IQVIA pharmaceutical data
domestic pharma market trends
Related News
- DCA Telangana cracks down on overpricing and misleading drug claims (22-02-2025)
- DCA busts unlicensed manufacturing drugs unit in Sangareddy (22-02-2025)
- A committee formed in Dehradun, to address the issue of companies producing counterfeit medications (22-02-2025)
- Govt Intensifies Inspections at Pharmaceutical Facilities to Ensure Quality (22-02-2025)
- BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation (22-02-2025)
- Bihar Takes Firm Stance Against Counterfeit Medicines, Health Secretary Issues Strong Directives (22-02-2025)
- Bombay HC Quashes Income Tax Reassessment Notice Against Lupin Ltd For AY 2016-17 (22-02-2025)
- Govt extends Rajeev Singh Raghuvanshi's tenure as DCGI by one year (22-02-2025)
- CrisprBits develops PathCrisp for detection of AMR (22-02-2025)
- Medicines valued at Rs 2 lakh confiscated from Hans Foundation Chhabra office (21-02-2025)